Unitree's STAR Market IPO and the R1: China's Humanoid Price Leader, by the Numbers

While Western humanoid companies raise billion-dollar rounds against future revenue, Unitree Robotics took a different route to the public markets: it showed up with actual sales and actual profit. On July 3, 2026, the Hangzhou-based company secured CSRC registration approval for an IPO on Shanghai's STAR Market — clearing review in a reported 104 days — and it is set to become the first pure-play humanoid robot listing.

What the prospectus shows

Unitree's filing reports revenue of about 1.71 billion yuan (roughly $250 million) for 2025, with adjusted net profit around 590 to 600 million yuan at a gross margin near 60 percent. According to reporting on the filing, humanoid robot revenue surpassed quadruped revenue for the first time in 2025, accounting for more than half of sales.

The volume numbers explain the margins. Unitree sold more than 5,500 humanoids in 2025 — about a third of the global market by volume — on top of more than 30,000 quadruped robots shipped between 2022 and September 2025. Unitree's strategy has been to own its supply chain: motors, reducers, controllers, and LiDAR are developed in-house, which is how it sustains prices competitors describe as impossible.

The humanoid lineup has iterated quickly: the H1 arrived in 2023, followed by the smaller G1 in 2024, the budget R1 in 2025, and the full-size H2 in late 2025. Where the H-series targets research and industrial pilots, the G1 and R1 are aimed squarely at developers, universities, and early commercial experimentation — the volume end of the market that Western vendors have largely ceded.

The R1 and the price floor

Unitree launched the R1 in July 2025 at 39,900 yuan — about $5,900 — undercutting every comparable humanoid by an order of magnitude and turning humanoids into something research labs, schools, and hobbyists could actually buy. Subsequent price cuts pushed the entry price for a consumer humanoid below 30,000 yuan, according to Gasgoo's reporting, with the base G1 starting at around 85,000 yuan after 2025 price adjustments.

The R1 is not an industrial machine; it is a lightweight platform aimed at developers and education. But its effect on the market has been industrial-scale: every Western vendor now prices against the question of why a humanoid should cost more than a car when Unitree sells one for less than a used motorcycle.

The IPO itself

Unitree plans to raise about 4.2 billion yuan (roughly $618 million) at an initial valuation near 42 billion yuan (about $6 billion). As of mid-July 2026 the offering was approved and in pricing, with a trading debut expected to follow. The 104-day review is being read in China as a signal of regulatory support for the embodied-AI sector, and a successful debut would give public-market investors their first direct exposure to humanoid robot sales rather than humanoid robot promises.

The risks are equally visible in the filing: a consumer-heavy revenue mix, intense domestic competition from Agibot, UBTECH, and dozens of newer entrants, and the open question of whether 2025's research-and-education demand converts into recurring industrial deployments. What is not in question is the baseline fact that distinguishes Unitree from nearly every peer: it already sells humanoids at volume, at a profit.

Sources

Gasgoo — Unitree wins IPO approval as robot makers face tougher profit challenges

AI in China — China's humanoid robot tsunami: 50,000 units, 700% growth

Tech Market Briefs — Unitree stock and IPO 2026: valuation, risks and bull case

RoboZaps — Unitree Robotics: every robot, real prices and the IPO